WEXFORD CAPITAL LP
Q1 2014 13F-HR Holdings
Net value change ($000)
+148,804
(12.7%)
New positions
89
Sold out positions
133
Turnover %
35.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| FANG | 103,240 | 18.3% |
| RHINO RESOURCE PARTNERS LP | 15,223 | 20.2% |
| MYLAN INC | 12,643 | 971.0% |
| DAVE | 12,288 | NEW |
| URI | 10,914 | 1998.9% |
| Bausch Health | 10,589 | NEW |
| Endo International plc | 9,959 | NEW |
| AAL | 8,509 | 37.9% |
| EOG | 7,944 | 122.6% |
| CARRIZO OIL & GAS INC | 7,259 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| SPRINT CORPORATION | -12,408 | -100.0% |
| DAL | -11,387 | -91.6% |
| GM | -10,773 | -100.0% |
| AMGN | -8,601 | -100.0% |
| MHK | -8,583 | -100.0% |
| *REPROS THERAPEUTICS INC | -8,028 | -76.3% |
| AER | -7,886 | -100.0% |
| TMO | -7,661 | -100.0% |
| PENN VIRGINIA CORP | -7,622 | -42.6% |
| BA | -7,208 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
2,082
(0.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|